Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma-Reference-Cited by-同舟云学术

Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma

Published:2012 Issue:2 Volume:45 Page:147-154
ISSN:0044-5991
Container-title:Acta Histochemica et Cytochemica
language:en
Short-container-title:Acta Histochem. Cytochem

Author:

Tsukada Hitomi¹,Muramatsu Toshinari¹,Miyazawa Masaki¹,Iida Tetsuji¹,Ikeda Masae¹,Shida Masako¹,Hirasawa Takeshi¹,Kajiwara Hiroshi²,Murakami Masaru³,Yasuda Masanori⁴,Mikami Mikio¹

Affiliation:

1. Department of Obstetrics and Gynecology, Tokai University School of Medicine

2. Department of Pathology, Tokai University School of Medicine

3. Department of Obstetrics and Gynecology, Tokai University Oiso Hospital

4. Department of Pathology, Saitama Medical University International Medical Center

Publisher

Japan Society of Histochemistry & Cytochemistry

Subject

Cell Biology,Histology,Physiology,Biochemistry,Pathology and Forensic Medicine

Link

https://www.jstage.jst.go.jp/article/ahc/45/2/45_11063/_pdf

Reference45 articles.

1. 1. Airley, R., Loncaster, J., Davidson, S., Bromley, M., Roberts, S., Patterson, A., Hunter, R., Stratford, I. and West, C. (2001) Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin. Cancer Res. 7; 928-934.

2. 2. Airley, R. E., Phillips, R. M., Evans, A. E., Double, J., Burger, A. M., Feibig, H. H., West, C. M. and Stratford, I. J. (2005) Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int. J. Oncol. 26; 1477-1484.

3. 3. Bristow, R. E., del Carmen, M. G., Pannu, H. K., Cohade, C., Zahurak, M. L., Fishman, E. K., Wahl, R. L. and Montz, F. J. (2003) Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol. Oncol. 90; 519-528.

4. 4. Bristow, R. E., Giuntoli, R. L. 2nd, Pannu, H. K., Schulick, R. D., Fishman, E. K. and Wahl, R. L. (2005) Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol. Oncol. 99; 294-300.

5. 5. Brown, R. S. and Wahl, R. L. (1993) Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72; 2979-2985.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can EBP50 and Merlin be used as diagnostic and prognostic markers for uterine smooth muscle tumors?;Biotechnology & Biotechnological Equipment;2024-05-20

2. Diagnostic performance of 18F-FDG PET or PET/CT in differential diagnosis of uterine leiomyomas and uterine sarcomas: systematic review and meta-analysis of the literature;Clinical and Translational Imaging;2022-03-17

3. Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas;European Journal of Hybrid Imaging;2021-09-03

4. Diffusion-weighted MRI and 18F-FDG-PET/CT imaging;Nuclear Medicine Communications;2017-01

5. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis;PLOS ONE;2016-11-08